2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Language English Country Ireland Media print-electronic
Document type Journal Article, Practice Guideline, Review
Grant support
MC_U137686849
Medical Research Council - United Kingdom
MC_UU_00017/4
Medical Research Council - United Kingdom
MC_UU_12026/6
Medical Research Council - United Kingdom
PubMed
31591002
DOI
10.1016/j.atherosclerosis.2019.08.014
PII: S0021-9150(19)31459-5
Knihovny.cz E-resources
- Keywords
- Apolipoprotein B, Cholesterol;, Dyslipidaemias, Familial hypercholesterolaemia, Guidelines, High-density lipoproteins, Lipoprotein remnants, Lipoprotein(a), Low-density lipoproteins, Total cardiovascular risk, Treatment (adherence), Treatment (drugs), Treatment (lifestyle), Triglycerides, Very low-density lipoproteins,
- MeSH
- Biomarkers blood MeSH
- Risk Reduction Behavior MeSH
- Adult MeSH
- Dyslipidemias blood diagnosis drug therapy epidemiology MeSH
- Risk Assessment MeSH
- Hypolipidemic Agents adverse effects therapeutic use MeSH
- Cardiovascular Diseases diagnosis epidemiology prevention & control MeSH
- Drug Therapy, Combination MeSH
- Consensus MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipids blood MeSH
- Risk Factors MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Practice Guideline MeSH
- Names of Substances
- Biomarkers MeSH
- Hypolipidemic Agents MeSH
- Lipids MeSH
References provided by Crossref.org
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
